Table 2.
Types of stakeholders whose views were sought for the implementation of MEAs.
| Author/ Year | Government/ Public service personnel | Manufacturer/ Pharmaceutical organization | Health plan manager/ Health insurers | Clinicians | Pharmacist (Various role) | Academics | Consumer advocates/ non-governmental organization members | Government Advisors/ Experts/ Health technology assessment agency | Patients |
|---|---|---|---|---|---|---|---|---|---|
| . Lu CY et al./2007 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| Jakub Adamski et al./2010 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| Espin J. etal./2011 | ✓ | ||||||||
| Sabine Vogler et al./2012 | ✓ | ||||||||
| Lisbet Coulton et al./2012 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| Ariel Hammerman et al./2012 | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Paige A. Thomson et al./2012 | ✓ | ||||||||
| Steve G. Morgan et al./2013 | ✓ | ||||||||
| Louis. P Garrison et al./2015 | ✓ | ✓ | ✓ | ||||||
| Melissa Thompson et al./2016 | ✓ | ✓ | ✓ | ||||||
| Arvind Mani et al./2016 | ✓ | ✓ | |||||||
| Taza Nazareth et al./2017 | ✓ | ✓ | |||||||
| Kim Pauwels et al./2017 | ✓ | ✓ | |||||||
| Steve G. Morgan et al./2017 | ✓ | ✓ | |||||||
| Joseph A. Goble et al./2017 | ✓ | ✓ | ✓ | ||||||
| Alessandra Ferrario et al./2017 | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| William C.N. Dunlop et al./2018 | ✓ | ✓ | ✓ | ||||||
| Christiane Maskineh et al./2018 | ✓ | ✓ | |||||||
| Jacoline C. Bouvy et al./2018 | ✓ | ✓ | ✓ | ||||||
| Alexandru M. Rotar et al./2018 | ✓ |